EUVIMEDEUVIMED entdecken
Open Access

MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders

Biji Mathew, Lorea Gamboa Acha, Leianne A Torres, Chun-Chieh Huang, Alice Liu, Sergey Kalinin, Kasey Leung, Yang Dai, Douglas L Feinstein, Sriram Ravindran, Steven Roth

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.01.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Biji Mathew und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, College of Medicine, University of Illinois-Chicago. Hauptthemen laut MEDLINE: MicroRNAs, Retinal Diseases, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIDCR NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cell (MSCs)-derived extracellular vesicles (EVs) are emerging therapeutic tools. Hypoxic pre-conditioning (HPC) of MSCs altered the production of microRNAs (miRNAs) in EVs, and enhanced the cytoprotective, anti-inflammatory, and neuroprotective properties of their derivative EVs in retinal cells. EV miRNAs were identified as the primary contributors of these EV functions. Through miRNA seq analyses, miRNA-424 was identified as a candidate for the retina to overexpress in EVs for enhancing cytoprotection and anti-inflammatory effects. FEEs (functionally engineered EVs) overexpressing miR424 (FEE424) significantly enhanced neuroprotection and anti-inflammatory activities in vitro in retinal cells. FEE424 functioned by reducing inflammatory cytokine production in retinal microglia, and attenuating oxygen free radicals in retinal Muller cells and microvascular endothelial cells, providing a multi-pronged approach to enhancing recovery after retinal ischemic insult. In an in vivo model of retinal ischemia, native, HPC, and FEE424 MSC EVs robustly and similarly restored function to close to baseline, and prevented loss of retinal ganglion cells, but HPC EVs provided the most effective attenuation of apoptosis-related and inflammatory cytokine gene expression. These results indicate the potential for EV engineering to produce ameliorative effects for retinal diseases with a significant inflammatory component. STATEMENT OF SIGNIFICANCE: We show that functionally engineered extracellular vesicles (FEEs) from mesenchymal stem cells (MSCs) provide cytoprotection in rat retina subjected to ischemia. FEEs overexpressing microRNA 424 (FEE424) function by reducing inflammatory cytokine production in retinal microglia, and attenuating oxygen free radicals in Muller cells and microvascular endothelial cells, providing a multi-pronged approach to enhancing recovery. In an in vivo model of retinal ischemia in rats, native, hypoxic-preconditioned (HPC), and FEE424 MSC EVs robustly and similarly restored function, and prevented loss of retinal ganglion cells, but HPC EVs provided the most effective attenuation of apoptosis-related and inflammatory cytokine gene expression. The results indicate the potential for EV engineering to produce ameliorative effects for retinal diseases with a significant inflammatory component.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRetinal DiseasesExtracellular VesiclesMesenchymal Stem CellsRatsAnimalsEndothelial CellsIschemiaCytokinesAnti-Inflammatory AgentsHypoxia

Stichwörter der Autor:innen

Extracellular vesiclesHypoxic preconditioningInflammationIschemiaMesenchymal stem cellsMicroRNAMicrogliaRetinal ganglion cells

Substanzen

MicroRNAsCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, College of Medicine, University of Illinois-Chicago.
  • Department of Oral Biology, College of Dentistry, University of Illinois-Chicago.
  • Department of Bioengineering, College of Engineering, University of Illinois-Chicago.
  • Department of Anesthesiology, College of Medicine, University of Illinois-Chicago; Jesse Brown Veterans Affairs, Chicago, IL.
  • Department of Oral Biology, College of Dentistry, University of Illinois-Chicago. Electronic address: sravin1@uic.edu.
  • Department of Anesthesiology, College of Medicine, University of Illinois-Chicago. Electronic address: rothgas@uic.edu.

Förderung

  • NEI NIH HHS
  • NIDCR NIH HHS
  • BLRD VA
  • NCATS NIH HHS
  • U.S. Department of Veterans Affairs
  • National Multiple Sclerosis Society
  • Glaucoma Research Foundation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Mathew, B., Acha, L. G., Torres, L. A., Huang, C. C., Liu, A., Kalinin, S., Leung, K., Dai, Y., Feinstein, D. L., Ravindran, S., & Roth, S. (2023). MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.01.014

Vancouver

Mathew B, Acha LG, Torres LA, Huang CC, Liu A, Kalinin S, et al. MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.01.014

BibTeX
@article{Mathew2023,
  author = {Mathew, Biji and Acha, Lorea Gamboa and Torres, Leianne A and Huang, Chun-Chieh and Liu, Alice and Kalinin, Sergey and Leung, Kasey and Dai, Yang and Feinstein, Douglas L and Ravindran, Sriram and Roth, Steven},
  title = {MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.01.014}
}
Kostenlos starten →